chrisvoncsefalvay/vaers-outcomes huggingface dataset:
With in a week of my first shot I developed shingles on my left side. On my back ribcage.; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 43-year-old adult female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7485), dose 1 via an unspecified route of administration, administered in Arm Right on 12Aug2021 at 18:30 (at the age of 43-year-old), as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included chicken pox as a child and lactose intolerance from an unknown date and unknown if ongoing. The patient had no covid prior vaccination. Concomitant medication(s) included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), kachava meal replacement, ion gut health, taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. The patient had not been covid tested post vaccination. On 20Aug2021 at 13:00, the patient experienced shingles on her left side and on her back ribcage. The clinical details of the event as follows: within a week of her first shot, she developed shingles on her left side, on her back ribcage. She had chicken pox as a child and am usually very healthy and well. Thought this was strange. The patient received treatment with Antiviral valacyclovir and Gabapentin 100MG to treat the events. The patient outcome of the event was Resolving at the time of this report.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of an unknown age and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX, (dose, route, lot # and expiration date were not provided). On an unknown date, after receiving the vaccine, the patient developed swelling, redness, "soreness" and "hot" at the injection site. The outcome of the events was unknown. The causality was not stated. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse (RN) concerning a 14-year-old white male with no known drug allergies (NKDA) and no pertinent medical history who on 25-Aug-2003 was vaccinated SC in the left arm with the first dose (0.5 mL) of varicell virus vaccine live (Lot #644090/1065M). There was no concomitant therapy or illness at the time of vaccination. The RN reported that 11-Sep-2003, the patient developed a varicella rash characterized by roughtly 20 pox. Unspecified medical attention was sought. The RN indicated that the patient had no other symptoms and no treatment or laboratory/diagnostic tests were required. On 15-Sep-2003, the patient recovered.
Case number PHEH2015US025709, is an initial spontaneous report received from a healthcare professional on 25 Nov 2015. This report refers to a 62-years-old male patient. Past medical history and concomitant medications were not reported. He was vaccinated with FLUCELVAX (batch number: 173538) at a dose of 0.5 ml intramuscularly on 21 Nov 2015 which was stored in a temperature range of 35.4 F for two days. No adverse event was reported following this administration error.
Information has been received from a nurse practitioner and a 27 year old female with a Naprosyn allergy and no medical history who on 6/26/78 at 1 year old, and February 1997, was vaccinated IM with the first and second dose of MMR, respectively. Concomitant medication included birth control tablets. On 11/23/04, the patient's titer was low for rubella. The patient reported she was not protected against rubella. Unspecified medical attention was sought. No product quality complaint was involved. Additional information is expected.
high fever (102-104)- 4 days, vomiting - 2 days, diarrhea - 2 days, tiredness - 5 days, weakness - 5 days  Treatment - rest, Tylenol (to reduce fever), fluid intake
Induration, redness, warmth. Spreading each day. No response to antibiotics or anti histamines.  Dx with cellulitis a d delayed local reaction.
A month after receiving the second dose of the Pfizer vaccine I started having chronic daily diarrhea alongside dehydration, nausea, tenesmus, fatigue, right sided sharp temporal migraine, and dizziness.
red, pruritic, tender rash which started on the back and started spreading.  no dob, no sob, no dyspnea
A report was received from a health care professional on 16Oct02, concerning a 7 month old female vaccinee who was inadvertently administered 0.25ml Fluvirin IM into vastus lateralis on the 15Oct02. On 15Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment.  PJP200200609, PJP200200671, PJP200200669, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
stomach pain, Dizziness, tinnitus, muscle aches, severe metallic taste; stomach pain, Dizziness, tinnitus, muscle aches, severe metallic taste; stomach pain, Dizziness, tinnitus, muscle aches, severe metallic taste; stomach pain, Dizziness, tinnitus, muscle aches, severe metallic taste; severe metallic taste; dose number=5; dose number=5; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Sep2022 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 65 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Type 2 Diabetic" (unspecified if ongoing); "Known allergies: latex" (unspecified if ongoing), notes: Known allergies: latex; "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa; "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "Known allergies: dairy" (unspecified if ongoing), notes: Known allergies: Dairy. The patient's concomitant medications were not reported. Past drug history included: Cipro, reaction(s): "Known allergies: Cipro", notes: Known allergies: Cipro; Codeine, reaction(s): "Known allergies: Codeine", notes: Known allergies: Codeine; Ceftin, reaction(s): "Known allergies: Ceftin", notes: Known allergies: Ceftin. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 3, UNKNOWN MANUFACTURER), for Covid-19 Immunization; Covid-19 vaccine (Dose: 4, UNKNOWN MANUFACTURER), for Covid-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), IMMUNISATION (non-serious) all with onset 13Sep2022, outcome "unknown" and all described as "dose number=5"; DYSGEUSIA (non-serious) with onset 17Sep2022, outcome "recovering", described as "severe metallic taste"; ABDOMINAL PAIN UPPER (non-serious), DIZZINESS (non-serious), TINNITUS (non-serious), MYALGIA (non-serious) all with onset 17Sep2022, outcome "recovering" and all described as "stomach pain, Dizziness, tinnitus, muscle aches, severe metallic taste".  Additional information: Patient received Plxlovid for trecament of covid 19 on start date 24Sep2022 and stop date 28Sep2022. patient had known allergies of  latex, Cipro, Codeine, Sulfa, Penicillin, Ceftin, dairy.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.  Amendment: This follow-up report is being submitted to amend previous information: Added the events General GI with stomach pain, Dizziness, tinnitus, muscle aches and severe metallic taste.
On Saturday, August 18th following vaccine administration, patient had what appeared to be 2 seizures lasting approx. 30 seconds, 2 minutes apart.  He was shaking, his eyes rolled back and afterwards he was unresponsive.  He was taken to ER immediately.  A CAT Scan and EEG were done with negative results.  He was kept in the hospital for 2 days for observation and discharged on Monday, August 20th.  He has had no seizures since that time and no other health problems.  He is being followed by a neurologist who has requested that patient not be given the DTaP vaccine.  He will be given Ped. DT.  11/01/2007 MR received for DOS 8/18-20/2007 with DX New onset seizure ? related to DPT.  Child presented to ER after episode of new onset seizure.  Neuro consult done by No further seizures during hospital observation.
Major tired, then I got super cold. I had uncontrollable shacking for about two hours or more (sometimes it felt like a seizure. . This started about 6PM Tuesday night. By 7AM I went from cold to hot/fever. I finally felt like the fever broke around 8PM Wednesday Night.
DVT (blood clot) in leg/her leg started to hurt; Dizziness; Headache; Fever; Chills; Didn't feel well; felt bad; had to go to bed for 3 days; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEEP VEIN THROMBOSIS (DVT (blood clot) in leg/her leg started to hurt) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION COMPLICATION (Didn't feel well), PYREXIA (Fever) and CHILLS (Chills). On 08-Apr-2021, the patient experienced DIZZINESS (Dizziness) and HEADACHE (Headache). In April 2021, the patient experienced FEELING ABNORMAL (felt bad) and DECREASED ACTIVITY (had to go to bed for 3 days). On 18-Apr-2021, the patient experienced DEEP VEIN THROMBOSIS (DVT (blood clot) in leg/her leg started to hurt) (seriousness criterion medically significant). On 04-Apr-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, DEEP VEIN THROMBOSIS (DVT (blood clot) in leg/her leg started to hurt), DIZZINESS (Dizziness), FEELING ABNORMAL (felt bad) and HEADACHE (Headache) outcome was unknown and VACCINATION COMPLICATION (Didn't feel well) and DECREASED ACTIVITY (had to go to bed for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not feel well for a couple of days. The events, fever and chills lasted for a day and half. On 07 Apr 2021 or 08 Apr 2021, the patient felt bad, experienced headaches and dizziness, and she had to go to bed for 3 days. On13 Apr 2021, the patient's leg started to hurt and she ended up going to hospital. On 18 Apr 2021, the patient was diagnosed with DVT  in her leg.  Concomitant medications reported included drug unspecified for blood pressure.  Treatment for the event included blood thinners.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Further information has been requested.
Information has been received from a pharmacist concerning a 70 year old female who on 11-OCT-2008 was vaccinated with one dose of ZOSTAVAX (Merck) (lot# 662971/1213) SQ.  Subsequently the patient developed a local reaction at the injection site.  The area was red and swollen about the size of 1 1/2 bandaids.  The patient was seen for follow up and it was reported that the reaction was resolving.  Follow-up information has been received from a pharmacist concerning a 70 year old female with allergy to ALENDRONATE NA (MSD, WAES 0811USA02064) who on 11-OCT-2008 was vaccinated with ZOSTAVAX (Merck) (lot# 662971/1213X) SQ into the left arm.  Concomitant therapy included influenza virus vaccine (unspecified).  On 11-OCT-2008 the patient experienced redness and swelling in injection site.  The patient's redness and swelling in injection site were slowly resolving.  The injection site was warm and still resolving on 03-NOV-2008.  Additional information is not expected.
Child had bliters on left arm around injection site. About 2 inches in diameter. Was warm to touch. Was taken to Pediatrician Dr. at hospital was treated with BENADRYL and BENADRYL cream.
I Started to have trouble coming up with words and experiencing forgetfulness. I Could still perform daily activities. Around May 5th I went in to see my doctor. He performed an EKG that came back normal. My primary care doctor recommended that I go into the ED to rule out a possible stroke. I Had multiple brain scans performed that came back positive for a stroke that happened on 5/1/2021. I was admitted into the hospital for 4 days. I still have trouble with forgetfulness.
The pt experienced a back ache approximately 3 hours post vax. The pt woke up in the middle of the night with nausea and vomiting, having body aches, with a fever and an extremely bad headache.
I am having a lot of pain from my right hip, down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 65-year-old male patient received pneumococcal 20-val conj vac (dipht crm197 protein) (PREVNAR 20), as dose numer unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing), notes: Anxiety; "Depression" (unspecified if ongoing), notes: Depression; "knee replace" (unspecified if ongoing). Concomitant medication(s) included: CARBIDOPA; LEVODOPA; CEFDINIR; CELEBREX; FLEXERIL [CEFIXIME]; LEXAPRO; MINOCYCLINE; FLUMAX [AMBROXOL HYDROCHLORIDE]; BUSPIRONE. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "I am having a lot of pain from my right hip, down". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia. Additional information: The patient got his vaccine during a doctor's appointment.   The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
14 year old male who developed acute onset shortness of breath, chest tightness, throat cloasing and dizziness upon standing within several hours of receiving Hep A vaccine #2 and T dose of Keflex for infected cyst.
I developed shingles on my lower right stomach, side, and back 3 weeks after second Moderna vaccine
Shot given in March. Still have, after 3 months, swelling, major joint pain and I can't lift my arm even waist high or reach out or up with it without experiencing shooting pains in arm. Doctor told me I'd just have to wait for it to wear off.
Information has been received from a physician, for GARDASIL, a Pregnancy Registry product, concerning a female patient with a history of sexually active before vaccination who in 2008 was vaccinated with her series of GARDASIL (exact dates unspecified). A recent Pap test (in 2010) was abnormal and tested positive for a high risk human papillomavirus (HPV) type. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. Follow-up information has been received from a medical assistant in the physician's office concerning the approximately 20 year old female patient. The medical assistant had no information on GARDASIL as it was administered at another office. She was not sure if the series was completed. The patient was "currently" pregnant (not reported initially) and the patient has not received a vaccine recently. The medical assistant confirmed that there was an abnormal PAP. There were no details of pregnancy provided. The outcome of the patient was not reported. No further information is available. This is a consolidation of two reports concerning the same patient.
Sweating, chills,  headache, head congestion, blurry vision, dizziness, chest pain, heart palpitations, congestive heart failure, tinnitus, postural tachycardia, loss of appetite, fatigue, fever (1 week) followed by low body temperature, weight loss, brain fog, jaw pain, TMJ, swollen lymph nodes, nausea, suppressed immune function.  8/11/09 Cardiology consult records received DOS 7/16/09 to 3/12/09. Assessment: History of chronic babesiosis and mild non-ischemic cardiomyopathy, left posterior fascicular block.  Patient reports that he had endocarditis that began after flu shot. Presents with vague left anterior chest pain with radiation into left arm. Dyspnea on exertion, palpitation, and near syncope. Fatigue. Weight loss, generalized lymphadenopathy, poor appetite. Eye pain. Dizziness and lightheadedness. Limited lifestyle. 9/29/09 Medical records received from ID physician for date range: 11/9/08 to 8/28/09. Patient presents with positive testing for Lyme Disease and babesia infection. C/O fatigue night sweats, blurred vision, poor sleeping, weight loss, easy brusing, pale in color, HA, head throbbing and pressure, right side jaw clenching, tinnitus, hair loss, SOB, chest pain, heart palpitations, N/V, constipation. DX: Neurologic Lyme Disease and babesia, elevated murcury level, heavy metal positive. TX with multiple IV medications.    10/30/09 Medical records received for DOS 11/06/06-11/30/06. Developed weakness and decreased vision/vision changes in R eye s/p vaccine.  Multiple PCP visits for fatigue and visual changes s/p vaccine.Viral syndrome.  Nausea, early satiety and weight loss. Maxillary sinusitis. Head CT otherwise normal. Vision 20/20. Neuro WNL.  H/O increased HGB. Decreasing. Developed diar on abx therapy for sinusitis. Probable c. diff. ED visit for weakness and visual changes. PE WNL. Labs WNL. Etiology unclear.
On 3/24/2021 about 1 hour, after I received the shot I started to have lower stomach cramps, they got more server as the night progressed. I could not sleep with the pain.  Then on 3/25/2021 at about 2 am in the morning I started getting a headache while still having stomach cramps. At about 7:00 am I had a fever of about 99.5 degrees then at about 11:00 am I had a fever of about 100.2 degrees and the stomach cramps were still there. I drank lots of water and Pedialyte to stay hydrated but had a very difficult time urinating. it was very little. At about 10 pm the cramps started to subsided but were still lightly present. my appetite went to almost nothing but soup for 2 days, I have had leg and arm cramps off and on during this process as well. I did not want to eat. today 3/27/2021 is the first day I have started to feel normal.
rash all over her body; itchy from head to toe; This is a spontaneous report from a contactable consumer (patient's mother).   A 19-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the age of 19-year-old via an unspecified route of administration, administered in left arm on 16Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included allergic to trees, alopecia. No family medical history. No history of all previously immunizations. No prior vaccination within 4 weeks. No additional vaccines administered on same date. No relevant tests. Ongoing Concomitant medications included hyoscyamine sulfate (LEVSIN) taken for abdominal discomfort; fluoxetine hydrochloride (PROZAC) taken for anxiety; cetirizine hydrochloride (CETIRIZIN) taken for allergic to trees.  On 17Apr2021 the patient developed a rash all over her body/ rash from top to bottom and was itchy from head to toe. Patient's mother took her to the emergency room and they gave her stuff to take care of it. When in the ER, got two meds for the rash that could be purchased over the counter. They said it was a reaction from the Covid shot, from the body giving something that shouldn't be there. Said if patient had a hard time breathing to come back. She was not admitted. The events outcome was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Breakthrough COVID. First vaccine dose 2/8/21, second dose 3/1/21. Patient is a 91 yo F with history of hypertension and hyperlipidemia experiencing acute SOB. Patient reports past 8-10 days has had cough, nasal congestion and SOB. The SOB worsened 2-3 days prior to admission. Patient also endorses chills, low grade fevers and fatigue but denies any other symptoms. Patient tested positive in ED on 1/24. ED workup included positive SARD-CoV-2 antigen, EKG showing controlled afib, Troponin-T high sensitivity positive (49), Chest XR showing bilateral pulmonary infiltrates consistent with pneumonia. Admitted with COVID pneumonia with sepsis.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 15-APR-2014 the patient was vaccinated subcutaneously with an improperly stored (that was exposed to 8F for 14 minutes) 0.5 ml dose of VARIVAX (Merck) (lot number: J005427 and expiration date: 02-MAY-2015). No adverse effect was reported. Additional information has been requested.
Had no symptoms for 1 week after injection. Then began with swelling, redness, itching, pain and heat at the injection site. Got very swollen. Took allergy medication. It is still red, itchy and swollen today but slowly improving since then.
Hives on back, arm and shoulder blade that are itchy and burning sometimes; Hives on back, arm and shoulder blade that are itchy and burning sometimes; Hives on back, arm and shoulder blade that are itchy and burning sometimes; This is a spontaneous report from a contactable consumer. A 95-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for Injection; Lot number: Unknown) via an unknown route of administration in the left arm on 29Jan2021 at 11:00 as single dose for COVID-19 immunization. The patient medical history included allergies to Penicillin, Bactrim and cholesterol medicines. The patient previously received the first dose of bnt162b2, via an unknown route of administration in the left arm on 07Jan2021 at 12:00 as single dose for COVID-19 immunization and experienced rash and hives on stomach, hip arm and shoulder blades on 11Jan2021 at 09:00 (the events resulted in doctor or other healthcare professional office/clinic visit and outcome was not recovered). The patient was healthy. The patients concomitant medications was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. On 29Jan2021, at 11:45, the patient developed hives on back, arm and shoulder blade that are itchy and burning sometimes. It was two weeks since second vaccine and it was still bothering the patient. The patient did not receive any treatment for the events. Since the vaccination, the patient has not been tested for COVID-19. The reporter assessed the events to be non-serious. The outcome for the events was not recovered.   Information on lot/batch number has been requested.
Post Polio syndrome symptoms. I have pain in the muscles my legs that I haven?t experienced in years. Sometimes it is very severe. The first shot brought on pain that lasted a few days but after the second shot the pain hasn?t gone away in 8 months.
Minimal immediate reaction to first dose on 12/31/20. After second dose 1/21/21 had fatigue and body ache for one day.  Sometime after second dose I've noted daily headaches, worse in morning and evening. Headaches are mild but persistent, localized to occipital area bilaterally. No other symptoms associated with this. I have rarely had headaches in the past but this is unusual as it happens every day for past 5-6 weeks. Wondering if this could be related to vaccine?